Predicting HLA-Specific Drug Hypersensitivity with Molecular Docking and Molecular Dynamics Simulations  by Yao, Xin-Qiu & Grant, Barry J.
Monday, February 17, 2014 411aglycoprotein (OMgp), contribute to inhibit central nerve system (CNS) regen-
eration after injuries; mainly by blocking axonal regrowth. The neurite
outgrowth inhibitor (Nogo-A) is a multi-domain transmembrane (TM) protein.
The loop domain, connecting the two hydrophobic C-terminus TM helices, is
referred to as Nogo-66. The inhibitory effect of Nogo is established when
Nogo-66 binds to its receptor (NgR) on the axon. Based on mutagenesis
studies performed in our lab, residues Ser 38, Asn 39, Ser 40, Leu 42, Arg
53 and Arg 54 affected the binding of Nogo-66 to NgR. Arg 53 and Arg 54
are among the most affected residues. On the other hand, combinatorial studies
on NgR, Asp 111, Asp 114, Asp 163 are the most residues contributing to the
interaction of NgR with Nogo-66 (1). To confirm this observation, High Am-
biguity Driven Docking (HADDOCK) expert interface server was used (2). As
starting structures for docking studies, we used the crystal structure of NgR
(PDB id 1OZN) and the NMR solution structure of Nogo-66 (PDB id
2KO2). The complex structures resulted from HADDOCK studies were in
agreement with our mutagenesis studies and provide insight into the mecha-
nism of inhibition.
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Protein-protein and protein-ligand recognition plays an essential role in many
biomolecular processes. Understanding the mechanisms of protein-ligand bind-
ing is also crucial for designing new and optimizing existing therapeutic agents,
and in different biotechnological applications. It is well known that solvation
effects, including hydrophobicity and solvent mediated hydrogen bonding,
are major factors implicated in biomolecular processes. Such processes often
involve slow conformational changes and exchange of solvent and ligand mol-
ecules between bulk solution and biomolecular cavities.
We develop new approaches for accurate account of molecular solvation ef-
fects in protein-ligand recognition and binding, which further extend the ligand
mapping protocols based on the molecular theory of solvation, a.k.a. the three-
dimensional reference interaction site model with the Kovalenko-Hirata
closure (3D-RISM-KH). Based on statistical mechanics, this theory provides
a natural link between different levels of coarse-graining details in a multiscale
description of solvation structure and thermodynamics, from highly localized
structural solvent and bound ligand molecules to effective desolvation poten-
tials and self-assembling nanoarchitectures in solvents of different composition
in a range of thermodynamic conditions.
Implemented in the new 3D-RISM-Dock protocol, the theory provides a quan-
titative estimate of binding affinities, based on a detailed physical description of
hydrogen bonding, hydrophobicity, and solvation entropic effects, with full ac-
count for molecular specificities, thermodynamic conditions, and concentration
effects. The theory accurately predicts the solvation structure of biomolecules.
This allows us to incorporate the 3D-RISM-KH description of structural solva-
tion in a new docking protocol. The latter has been successfully applied to pre-
dict the binding modes of the periplasmic binding proteins in situations when
structural solvation and desolvation effects are of importance. We also show
that the 3D-RISM-KH theory provides valuable information on the role of
the solvation entropic effects in the ligand binding and large scale conformation
dynamics of proteins.
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A simple and powerful method for enhancing conformational transitions of
proteins, referred as "Fluctuation Flooding Method (FFM)", is proposed. In
FFM, biologically relevant anisotropic fluctuations of proteins are firstly
characterized by the principal component analysis (PCA) from trajectories
of molecular dynamics (MD) simulations. Then largely fluctuated snapshots
along the anisotropic directions are assumed as candidates that tend to induceconformational transitions with high probabilities and selected as initial struc-
tures for Multiple Independent Molecular Dynamics (MIMD) simulations. In
MIMD, a series of short time MD simulations are performed with re-
generating initial velocities for selected candidates to enhance conformational
transitions. Due to the re-organizations of the initial velocities, some of the can-
didates might make a conformational transition to another meta-stable states.
The multiple trajectories from MIMD are characterized by the PCA to extract
largely fluctuated snapshots as candidates for the next MIMD step. These pro-
cedures are repeated until distributions of the conformational sampling are well
converged. In addition to FFM, Multiple Independent Umbrella Sampling
(MIUS) using reference structures selected from MIMD can provide Free En-
ergy Landscape (FEL). FEL calculations by the combination with MIUS enable
us to quantitatively determine conformational transition pathways and estimate
structural stabilities of newly found meta-stable states.
To assess the reliability of the proposed method, we applied FFM to a toy
model and confirmed that probability densities calculated from FFM showed
a good agreement with the analytical solution. As an application to a real pro-
tein system, we applied FFM to T4-Lysozome in explicit water. Although 1-ms
canonical MD failed to sample the closed state, FFM with 10-ns MIMD suc-
ceeded in finding conformational transitions from the open to closed states,
where the minimum root-mean square deviation between the predicted closed
and experimental X-ray structures was 0.76 A˚.
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Mutational analysis is the bread and butter of experimental protein biophysics;
however, in simulation studies, mutational analysis remains a major challenge
because the computational costs scale proportional to the number of mutants.
We suggest a way out of this connundum, by using large-scale simulation of
a wild-type protein as an informative prior on the simulations of mutants.
With an ansatz that mutation perturbs the rates of inter-conversion between
an unknown subset of the conformational states of the protein, we introduce
a Bayesian adaptive simulation framework in which these perturbations are
automatically perused and discovered in a maximum expected information
gain criterion. Preliminary data suggests that this approach can lead to speedups
on the order of ten times in simulations of mutants, by focusing molecular dy-
namics sampling in regions of phase-space that are perturbed with respect to the
wild-type.
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Adverse drug reactions are a leading cause of morbidity and mortality with esti-
mated annual in-patient costs of over $100 billion in the US alone. A growing
number of the most sever adverse reactions, termed idiosyncratic hypersensitiv-
ities, are observed to be immune system mediated with genetic associations to
specific patient human leukocyte antigen (HLA) alleles. However, the underly-
ing mechanisms of such genetic associations are still unclear. Improved knowl-
edge of these mechanisms is highly desirable for prognosis and prevention as
well as the optimal utilization of drug therapies. Recently, we combined in sil-
ico and in vitro approach to demonstrate that the antiviral drug abacavir can
bind inside the antigen binding cleft of HLA B*57:01 and alter its specificity
for self-peptides presented to T cells. This finding, which has been indepen-
dently reproduced, supports a new drug induced "altered peptide repertoire
model" for HLA-drug associated hypersensitivities and explains the specificity
of abacavir for HLA B*57:01 over other alleles. Here we describe the com-
bined application of structural modeling, molecular docking and molecular dy-
namics simulations to further examine the generality of this model to additional
drugs with known HLA-drug associated hypersensitivities. The predictive po-
wer of our in silico approach was evaluated with a benchmark containing mixed
drug hypersensitivity associated and unassociated HLA alleles. The critical en-
ergetic features of HLA-drug binding were further investigated via molecular
dynamics simulations. For abacavir, the antiepileptic drug carbamazepine,
and the antihyperuricemic drug allopurinol these simulations identified the
variant specific residue-wise determinants of HLA-drug interactions. Our
studies represent a first step toward the development of preclinical screening
processes that aims to highlight drugs with a high risk of causing drug hyper-
sensitivity.
